Telesis Bio, Inc. (TBIO) Financials

TBIO Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 24.7 million 20.9 million
June 30, 2024 52.7 million 42.8 million
March 31, 2024 63.3 million 41.7 million
Dec. 31, 2023 70.4 million 40.9 million

TBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -7.0 million 566000
June 30, 2024 -5.4 million 869000
March 31, 2024 -3.7 million 766000
Dec. 31, 2023 -7.6 million 616000

TBIO Net Income

No data available :(

TBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 4.5 million 5.8 million 10.5 million
June 30, 2024 10.2 million 5.3 million 30.3 million
March 31, 2024 15.7 million 5.2 million 30.9 million
Dec. 31, 2023 19.2 million 5.3 million 29.1 million

TBIO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 1.8 million
June 30, 2024 1.7 million
March 31, 2024 29.8 million
Dec. 31, 2023 30.0 million

TBIO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 55000 2.2 million 4.0 million 880000
June 30, 2024 81000 2.5 million 7.2 million 1.7 million
March 31, 2024 502000 2.9 million 5.9 million 1.7 million
Dec. 31, 2023 252000 3.0 million 7.2 million 3.6 million

TBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 1.6 million 557000
June 30, 2024 1.6 million 2.3 million
March 31, 2024 3.4 million 3.2 million
Dec. 31, 2023 7.0 million 2.9 million

TBIO

Price: $0

52 week price:
0.00
1.55

Earnings Per Share: -30.42 USD

Exchange: PNK

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 19200

Market Capitalization: 4.2 million

Links: